KYNTRA BIO INC
KYNBNASDAQ🏆 #4671 by market capEarnings Nov 9 · PostUS Equity
$6.79▼ $0.11 (−1.59%)
Market closed · at closeTrack KYNB
Get earnings, price moves & breaking news on Telegram
24h▼ 1.6%
7d▼ 6.3%
14d▼ 11.0%
30d▼ 14.2%
ytd▼ 22.4%
1y▼ 44.0%
🏦Market Cap
$27M
Small Cap
📈Revenue Growth (YoY)
-78.3%
Declining
📊Gross Margin
18.1%
Thin
💵FCF Margin
-824.4%
Thin
⚖️P/S Ratio
6.0x
Fair
Otter Score
72
Fair
KYNTRA BIO INC
KYNBAnalyst Ratings
Price
$6.79
Total
15
Raised
3
Lowered
6
Avg PT
$28.00
H / L
$28 / $28
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-01 | — | — |
B of A Securities | Downgraded | Neutral → Underperform | 2023-08-07 | — | — |
Goldman Sachs | Reiterated | Sell | 2023-06-26 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2023-06-25 | — | — |
Stifel | Downgraded | Buy → Hold | 2023-06-25 | — | — |
William Blair | Downgraded | Outperform → Market Perform | 2023-06-25 | — | — |
Cowen & Co. | Reiterated | Market Perform | 2023-02-27 | — | — |
SVB Leerink | Reiterated | Outperform | 2021-08-09 | — | — |
JP Morgan | Upgraded | Underweight → Neutral | 2021-04-06 | — | — |
Mizuho | Downgraded | Buy → Neutral | 2021-04-06 | — | — |
Jefferies | Downgraded | Buy → Hold | 2021-03-01 | — | — |
PiperJaffray | Reiterated | Neutral | 2019-04-12 | — | — |
Citigroup | Upgraded | Neutral → Buy | 2018-12-18 | — | — |
Leerink Swann | Reiterated | Outperform | 2018-10-14 | — | — |
Credit Suisse | Upgraded | Neutral → Outperform | 2016-02-10 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-09-01
—
—
B of A Securities
Downgraded · Neutral → Underperform · 2023-08-07
—
—
Goldman Sachs
Reiterated · Sell · 2023-06-26
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2023-06-25
—
—
Stifel
Downgraded · Buy → Hold · 2023-06-25
—
—
William Blair
Downgraded · Outperform → Market Perform · 2023-06-25
—
—
Cowen & Co.
Reiterated · Market Perform · 2023-02-27
—
—
SVB Leerink
Reiterated · Outperform · 2021-08-09
—
—
JP Morgan
Upgraded · Underweight → Neutral · 2021-04-06
—
—
Mizuho
Downgraded · Buy → Neutral · 2021-04-06
—
—
Jefferies
Downgraded · Buy → Hold · 2021-03-01
—
—
PiperJaffray
Reiterated · Neutral · 2019-04-12
—
—
Citigroup
Upgraded · Neutral → Buy · 2018-12-18
—
—
Leerink Swann
Reiterated · Outperform · 2018-10-14
—
—
Credit Suisse
Upgraded · Neutral → Outperform · 2016-02-10
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space